Amarin is very busy in discussions about marketing partnership outside USA.Most probably,it will be announced in next 30 days.
Manufacturer of VASCEPA is already public.
Aggressive marketing in USA is already going on--with Vascepa or Anchor trials information in appropriate sources and meetings.
Reliant Pharm. marketed Lovaza in 2005,GSK made a bid in 2007 after Sales data was available. Amarin has hired top marketing management who worked at Reliant with Joe Zakrzewski in 2006. Joe was Chief Operating officer at Reliant and CEO was a founder of Reliant.
Reliant was a small private company until 2005.Lovaza launch made it big. Reliant was in the process of going public in 2007--when GSK bid for the whole co.
Reliant looked for marketing partnership in 2004-2005,but was not successful--so Lovaza was launched by Reliant.
As far as selling overseas--Reliant had rights to LOVAZA in USA and Puerto Rico from PRONOVA(patent holders).